Lansonew 30

🟧 Lansonew 30 mg capsules

✅ Medication:

Lansonew 30 mg

✅ Chemical Composition:

Each capsule contains:
Lansoprazole 30 mg

✅ Therapeutic Class:

Proton pump inhibitor
Antacid
Effective treatment for gastroesophageal reflux and duodenal ulcer

✅ Dosage Form – Route:

Capsules – Oral route

✅ Pharmaceutical Form:

Enteric‑release capsules

✅ Properties:

Lansonew 30 mg is the primary treatment option for gastroesophageal reflux disease (GERD) and gastrointestinal ulcers associated with H. pylori infection or NSAID use.

It provides long‑term control of acid secretion, with proven efficacy in healing ulcers within 2–4 weeks of treatment.